BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10201892)

  • 1. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.
    Losman JA; Chen XP; Hilton D; Rothman P
    J Immunol; 1999 Apr; 162(7):3770-4. PubMed ID: 10201892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.
    Haque SJ; Harbor PC; Williams BR
    J Biol Chem; 2000 Aug; 275(34):26500-6. PubMed ID: 10950967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
    Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
    EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family of cytokine-inducible inhibitors of signalling.
    Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
    Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells.
    Hebenstreit D; Luft P; Schmiedlechner A; Duschl A; Horejs-Hoeck J
    Mol Immunol; 2005 Feb; 42(3):295-303. PubMed ID: 15589317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site.
    Hebenstreit D; Luft P; Schmiedlechner A; Regl G; Frischauf AM; Aberger F; Duschl A; Horejs-Hoeck J
    J Immunol; 2003 Dec; 171(11):5901-7. PubMed ID: 14634100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation.
    Venkataraman C; Leung S; Salvekar A; Mano H; Schindler U
    J Immunol; 1999 Apr; 162(7):4053-61. PubMed ID: 10201928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS proteins: negative regulators of cytokine signaling.
    Krebs DL; Hilton DJ
    Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease.
    Diamond P; Doran P; Brady HR; McGinty A
    J Nephrol; 2000; 13(1):9-14. PubMed ID: 10720209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pim serine/threonine kinases regulate the stability of Socs-1 protein.
    Chen XP; Losman JA; Cowan S; Donahue E; Fay S; Vuong BQ; Nawijn MC; Capece D; Cohan VL; Rothman P
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2175-80. PubMed ID: 11854514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.
    Dickensheets HL; Venkataraman C; Schindler U; Donnelly RP
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10800-5. PubMed ID: 10485906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
    Cooney RN
    Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new role for SOCS in insulin action. Suppressor of cytokine signaling.
    Krebs DL; Hilton DJ
    Sci STKE; 2003 Feb; 2003(169):PE6. PubMed ID: 12582200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suppressors of cytokine signalling (SOCS).
    Kile BT; Alexander WS
    Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.